Phathom Pharmaceuticals, Inc. — Director's Dealing 2021

May 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2021-05-21

Reporting Person: COLA MICHAEL F (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-21	Stock Option (Right to Buy)	$35.49	A	12500	Acquired	2031-05-20	Common Stock (12500)	Direct

Footnotes

F1: The option was granted pursuant to the Registrant's Non-Employee Director Compensation Program. The option shall vest and/or become
exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Registrant's
stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.